| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.91B | 24.03B | 18.87B | 15.25B | 8.89B | 7.51B |
| Gross Profit | 14.06B | 13.78B | 10.20B | 8.03B | 4.30B | 3.56B |
| EBITDA | 8.14B | 8.10B | 6.20B | 4.62B | 2.00B | 1.72B |
| Net Income | 4.85B | 5.07B | 3.85B | 3.00B | 1.65B | 1.11B |
Balance Sheet | ||||||
| Total Assets | 29.35B | 29.53B | 25.83B | 19.61B | 16.35B | 12.56B |
| Cash, Cash Equivalents and Short-Term Investments | 13.49B | 12.65B | 9.45B | 6.64B | 4.72B | 4.57B |
| Total Debt | 3.29B | 2.91B | 2.13B | 1.16B | 1.28B | 39.94M |
| Total Liabilities | 8.24B | 8.10B | 8.09B | 5.27B | 4.48B | 2.18B |
| Stockholders Equity | 21.11B | 21.43B | 17.74B | 14.33B | 11.87B | 10.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.27B | 2.90B | 2.62B | 1.01B | 1.29B |
| Operating Cash Flow | 0.00 | 6.00B | 3.28B | 3.11B | 1.41B | 1.61B |
| Investing Cash Flow | 0.00 | -1.88B | -194.81M | -788.10M | -2.10B | -321.06M |
| Financing Cash Flow | 0.00 | -700.47M | -213.34M | -773.99M | 832.59M | -236.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥883.83B | 12.89 | 11.99% | 0.65% | 8.50% | 14.06% | |
78 Outperform | ¥320.90B | 8.42 | ― | 2.04% | -0.69% | -29.88% | |
75 Outperform | ¥1.12T | 19.48 | 11.14% | 1.46% | 3.92% | 9.99% | |
75 Outperform | ¥452.24B | 28.58 | 7.44% | 1.76% | -0.89% | 53.87% | |
74 Outperform | ¥600.32B | 44.29 | 4.03% | 2.25% | 3.97% | -41.76% | |
73 Outperform | ¥258.50B | 13.13 | 25.32% | 2.30% | 6.85% | 10.88% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |